[Clinical application of NK-631, a new bleomycin to head-and-neck malignant tumors (author's transl)].
D000328:Adult; D000368:Aged; D001761:Bleomycin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D001761:Bleomycin